PROM1 and acute lymphoblastic leukemia: To assess drug sensitivity profiles, we performed CellTiter-Glo cell-viability assay on FACS CD133+ and CD133–CRISPRKMT2A::AFF1 blasts after treatment with 4 ALL drugs: prednisolone, L-asparaginase, daunorubicin, and vincristine.